Wockhardt shares jump 3% as NIH to support trial of company's antibiotic
The company informed that the trial will be conducted at NIAID’s Phase I clinical trial units in the USA. NIAID will sponsor the investigational new drug (IND) application for the study.
Source: businesstoday.in